InflaRx is a young biotechnology company with the goal of developing antibodies for therapeutic use in inflammatory diseases. The research focus is in the area of acute life-threatening inflammation (use in intensive care units) and is currently being expanded to chronic inflammatory diseases and autoimmune diseases. The leading product candidate (IFX‑1) is in the so-called clinical phase II testing on patients.
bm|t beteiligungsmanagement thueringen gmbh
M.-Welsch-Str. 6a · 99084 Erfurt · Germany
+49 361 · 7447-601 | info@bm-t.de
bm|t beteiligungsmanagement thueringen gmbh
M.-Welsch-Str. 6a · 99084 Erfurt · Germany | +49 361·7447-601 | info@bm-t.de
Location: Germany, Thuringia, Jena
Total raised: $63M
Investors 4
| Date | Name | Website |
| - | bm-t betei... | bm-t.de |
| - | RA Capital... | racap.com |
| - | Bain Capit... | baincapita... |
| - | Affentrang... | aasa.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| - | - | $63M | - |
Mentions in press and media 24
| Date | Title | Description | Source |
| 09.03.2024 | bm|t Venture Insights 1/18: 15 years of bm|t — A brief Histo... | bm|t is celebrating its 15th birthday in 2018 and some predecessor organizations/funds date b... | bm-t.de/en... |
| 09.03.2024 | bm|t Venture Insights 4/19: The Decade Past, The Decade Ahea... | THE 2010S DECADE bm|t and our Investee-Partners, who are the true drivers of our success, progre... | bm-t.de/en... |
| 09.03.2024 | bm|t Venture Insights 4/18: Momentum and Nonlinearities | In the example mentioned above, the marble that more quickly transformed its potential energy i... | bm-t.de/en... |
| 01.02.2024 | Thuringia launches another fund with the Thüringer Zukunftsf... | Another capital injection for the Thuringian economy: With the €40 million “Thüringer Zukunfts... | bm-t.de/en... |
| 27.10.2023 | 20 years pioneering Thuringia’s financial landscape: Intervi... | In recent years, Germany’s venture capital activity has witnessed robust growth, with regions l... | bm-t.de/en... |
| 16.05.2023 | WuXi Biologics Announces Manufacturing Partnership with Infl... | WuXi Biologics is the manufacturing partner of InflaRx for Gohibic (vilobelimab), a first-in-class m... | en.prnasia... |
| 12.04.2023 | FDA Authorizes New Antibody Treatment For Severe Covid-19 | Microbiology illustration of prescription drug in the human systemgetty | forbes.com... |
| 05.01.2022 | InflaRx N : 01-2022-InflaRx Announces Presentation at J.P. M... | Jena, Germany, January 5, 2022 - InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical com... | marketscre... |
| 09.09.2021 | InflaRx N : 09-2021-InflaRx to Present at the H.C. Wainwrigh... | Jena, Germany, September 9, 2021 - InflaRx (Nasdaq: IFRX), a clinical-stage biopharmaceutical compan... | marketscre... |
| 08.09.2021 | InflaRx N : 09-2021-InflaRx to Proceed with Pivotal Developm... | InflaRx received feedback from FDA within its Type A meeting which is supportive of a new primary en... | marketscre... |
Show more